Valganciclovir (Valganciclovir) Instructions: Correct Taking Method and Dosage Guide

Valganciclovir is a nucleoside antiviral drug widely used to treat diseases caused by cytomegalovirus (CMV). Cytomegalovirus (CMV) Infection often poses a significant threat to patients with weakened immune systems, especially AIDS patients, organ transplant patients, and other immunocompromised individuals. Vancevi inhibits CMV DNA polymerase and reduces viral replication, thereby effectively treating or preventing CMV-related diseases. Its primary applications include the treatment of CMV retinitis, and the prevention of CMV in high-risk patients.

1. Indications

The main indications for Vancevir include the treatment or prevention of certain disease conditions in adult and pediatric patients:

1. Adult patients:

TreatmentCMV retinitis: For patients with AIDS, cytomegalovirus infection may cause retinitis, which can lead to blindness in severe cases. The use of Vancevir in this case can effectively reduce viral replication and improve visual prognosis.

Prevention of CMV infection in organ transplantationCMV infection: Vancevir is used to prevent cytomegalovirus (CMV) infection in heart, kidney, and kidney-pancreas transplant patients. Such patients are susceptible to CMV infection due to immunosuppressive treatment.

2. Pediatric patients:

Preventing CMV infection in high-risk kidney transplant patientsCMV infection: For high-risk kidney transplant patients aged 4 months to 16 years old, Vancevi can effectively prevent the occurrence of CMV.

Prevention of CMV infection in high-risk children with heart transplantationCMV infection: For children aged 1 month to 16 years old who have received heart transplantation, Vancevir is also used to prevent CMV infection.

2. Usage and dosage

The dosage and regimen of Vancevir will vary based on the patient's age, condition, and specific goals of treatment. Proper usage and dosage are critical to therapeutic effectiveness and safety.

1. Adult patients

1) TreatmentCMV retinitis:

Starting dose: For adult patients, the usual starting dose of Vancevir is 900 mg twice daily for 21 days. This high-dose regimen is designed to quickly inhibit viral replication and control the disease.

Maintenance dose: After completing21 days of initial treatment, patients can adjust to once a day and continue to take 900mg to maintain the therapeutic effect. Maintenance treatment usually continues until the condition is stable, for how long determined by your doctor.

2) Prevention of CMV infection in organ transplantationCMV infection:

Heart and kidney-pancreas transplantation: For patients with heart and kidney-pancreas transplantation, Vancevir should be taken starting within 10 days after transplantation at 900 mg once a day and continued until 100 days after transplantation.

Kidney transplant: For kidney transplant patients, Vancevir should be taken within 10 days after transplantation, 900 mg once a day, and the treatment cycle is 200 days.

2. Pediatric patients

1)—CMV prevention in kidney transplantation:

For kidney transplant patients4 months to 16 years old, the dose of Vancevi is calculated based on the patient's body surface area (BSA) and creatinine clearance (CrCl). The formula for specific dosage is: 7 × BSA × CrCl. Treatment should begin within 10 days after transplantation and continue until 200 days after transplantation.

2) CMV prevention in heart transplantationCMV prevention:

For heart transplant patients ages 1 month to 16 years of age, dose calculations are also based on body surface area and creatinine clearance, with treatment beginning within 10 days after transplantation and continuing until 100 days after transplantation.

3. Correct use method

Vancevi is an oral drug and should be taken strictly according to the doctor's instructions. Medications should be taken regularly every day, preferably after meals, to reduce the occurrence of gastrointestinal discomfort. The tablets can be swallowed whole or dissolved in water if necessary. Whether it is treatment or prevention, patients should ensure that they take their medication on time every day and avoid missing doses. If a dose is missed, the patient should replenish the missed dose as soon as possible. However, if the next dose is approaching, the missed dose should be skipped and the next dose should be taken on time. Do not take a double dose at one time.

Reference materials:https://go.drugbank.com/drugs/DB01610